ラクトフェリンの世界市場規模：機能別、用途別、地域範囲別および予測

ラクトフェリンの市場規模と予測

ラクトフェリン市場規模は、2024年に20億6,000万米ドルと評価され、2026～2032年にかけてCAGR 7.9%で成長し、2032年には44億9,000万米ドルに達すると予測されます。

健康や食生活に対する消費者の意識の高まりや、皮膚に関連する健康問題の発生率の上昇が需要を牽引していると考えられます。ラクトフェリンは、抗ウイルス、抗菌、抗寄生虫、触媒、抗アレルギー活性と品質を提供すると考えられており、医薬品とパーソナルケアセグメントでの製品需要を増加させると考えられます。米国皮膚科学会によると、ニキビは米国で最も一般的な皮膚トラブルであり、毎年4,000万人から5,000万人に影響を与えています。ラクトフェリンの世界市場レポートは、市場の全体的な評価を記載しています。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界のラクトフェリン市場の定義

ラクトフェリンは牛乳由来の栄養補助食品です。ラクトフェリンは牛の乳から抽出され、パーソナルケアアイテム、乳児用調製粉乳、歯磨き粉、栄養補助食品を含む様々な市販食品に配合されます。この多機能タンパク質は、温度や物理的・化学的制約によってコンフォメーションが変化します。変性を避けるためには、ラクトフェリン粗抽出物とラクトフェリン含有食品のプロセス因子を強化し、最適化する必要があります。

特に、胃潰瘍や腸潰瘍、下痢、C型肝炎を改善する効果があります。また、抗酸化物質として作用し、細菌やウイルスの病気から身を守る。組織の損傷防止、がん予防、免疫反応の活性化など、体にいくつかの健康上の利点をもたらします。摂取は安全だが、過剰摂取は悪影響を及ぼす可能性があります。店舗やオンラインで簡単に入手できます。粉末で販売されていることが多いです。ラクトフェリンには抗ウイルス作用、抗菌作用、抗発がん作用、抗炎症作用があります。このタンパク質の抗菌・抗真菌作用は、主に体内の防御機構として機能します。ラクトフェリンは抗菌・抗真菌作用があり、人間の新生児に適しています。

世界のラクトフェリン市場概要

にきびは、米国、カナダ、ドイツなどの先進国でより一般的になってきており、ラクトフェリンによるにきび治療に関する確認された証言や研究結果は、予測期間を通じて製品生産者の成長機会を促進すると考えられます。世界のパーソナルケア部門は数十億米ドル規模であり、従来型実店舗型ビジネスからニッチ小売店やインターネット小売店へとシフトしつつあります。あらゆる年代の女性が、オフラインの小売店で購入する前にオンラインポータルを訪れて商品について学ぶという、クロスチャネル購入方法を好んでいます。

ブランドオーナーの製品マーケティング活動の結果としての消費者意識は、副作用が少なく効率性の向上したオーガニック製品への嗜好とともに、製品需要をさらに押し上げると予測されます。ラクトフェリンは、表皮細胞との結合組織を活性化し、皮膚を再構築することによって、皮膚免疫反応の軽減と創傷治癒に広く使用されています。その抗炎症特性は、より大きなニキビや嚢胞の生成を防ぐのに役立ちます。ラクトフェリンは、胃腸の炎症性疾患の治療と予防に有用であることが、いくつかの臨床検査で示されています。

腸の健康に関する消費者の知識の高まりと、過敏性腸運動や腹部膨満感を回避し、腸の炎症を抑えるための製品需要の高まりは、予測期間を通じてラクトフェリン市場の拡大を促進すると予想されます。しかし、下痢などのラクトフェリン使用に伴う悪影響は、ラクトフェリン市場の拡大に大きな障害となると考えられます。ラクトフェリンに関連する高価格は、市場の拡大をさらに妨げると考えられます。母乳育児を促進しようとする政府の試みも、ラクトフェリン市場の成長率を鈍らせると考えられます。

目次

第1章 世界のラクトフェリン市場の導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のラクトフェリン市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 ラクトフェリンの世界市場：機能別

• 概要
• 鉄吸収
• 抗炎症
• 腸内フローラ保護
• 抗菌
• 免疫細胞刺激
• 抗酸化作用

第6章 ラクトフェリンの世界市場：用途別

• 概要
• 飲食品
• 乳児用調製粉乳
• スポーツ機能性食品
• 医薬品
• パーソナルケア製品
• 飼料

第7章 ラクトフェリンの世界市場、地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界のラクトフェリン市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第9章 企業プロファイル

• InVitria
• Hilmar Cheese Company
• Glanbia plc
• Pharming Group NV
• APS BioGroup
• FrieslandCamina
• Synlait Milk Ltd.
• Ferrin-tech LLC
• Ingredia SA
• Tatura Milk Industries Ltd.

第10章 付録

• 関連調査

Lactoferrin Market Size And Forecast

Lactoferrin Market size was valued at USD 2.06 Billion in 2024 and is projected to reach USD 4.49 Billion by 2032, growing at a CAGR of 7.9% from 2026 to 2032.

The increased consumer awareness of health and diet, as well as the rising occurrence of skin-related health issues, are likely to drive demand. Lactoferrin is thought to offer antiviral, antibacterial, antiparasitic, catalytic, and anti-allergic activities and qualities, which will increase product demand in the pharmaceutical and personal care sectors. Acne is the most common skin problem in the United States, impacting 40 to 50 million individuals each year, according to the American Academy of Dermatology. The Global Lactoferrin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Lactoferrin Market Definition

Lactoferrin is a nutritional supplement derived from milk. Lactoferrin is extracted from bovine milk and then mixed into a variety of commercial food products, including personal care items, infant formula, toothpaste, and nutraceuticals. Temperature, as well as physical and chemical restrictions, can trigger conformational changes in this multi-function protein. To avoid denaturation, the lactoferrin crude extract and process factors for lactoferrin-containing food items should be enhanced and optimized.

Among other things, it can assist with stomach and intestinal ulcers, diarrhea, and hepatitis C. It also acts as an antioxidant, which protects against bacterial and viral illnesses. It provides several health advantages for the body, including tissue damage prevention, cancer prevention, immune response activation, and other benefits. It is safe to consume, but excessive doses might have negative consequences. It is readily accessible in stores and online. It is most often found as a powder. Lactoferrin has antiviral, antibacterial, anti-carcinogenic, and anti-inflammatory properties. The protein's antibacterial and antifungal activities serve largely as a defense mechanism in the body. Lactoferrin is antibacterial and antifungal, making it suitable for human newborns.

Global Lactoferrin Market Overview

Acne is becoming more common in developed countries such as the United States, Canada, and Germany, and confirmed testimonies and study findings for lactoferrin-induced acne therapy are likely to drive growth opportunities for product producers throughout the projection period. The worldwide personal care sector is worth billions of dollars and is shifting away from traditional brick-and-mortar businesses and towards niche and internet retailers. Women of all ages prefer a cross-channel purchase method, where they visit online portals to learn about the goods before purchasing from an offline retail location.

Consumer awareness as a result of brand owners' product marketing operations, along with a preference for organic products with fewer side effects and improved efficiency, is predicted to boost product demand even further. Lactoferrin is widely used in the reduction of dermal immune response and wound healing by activating connective tissue with epidermal cells and rebuilding the skin. Its anti-inflammatory properties help to prevent the production of bigger zits and cysts. Lactoferrin has been shown in several clinical trials to be useful in the treatment and prevention of gastrointestinal inflammatory diseases.

Rising consumer knowledge about gut health, along with rising product demand to avoid irritable bowel movement and bloating, as well as to reduce intestinal inflammation, is expected to drive the expansion of the Lactoferrin Market throughout the projected period. However, negative effects associated with lactoferrin use, such as diarrhea, will pose a significant hurdle to the expansion of the Lactoferrin Market. The high prices connected with lactoferrin will further stymie market expansion. Increased government attempts to promote breastfeeding will also slow the growth rate of the Lactoferrin Market.

Global Lactoferrin Market: Segmentation Analysis

The Global Lactoferrin Market is Segmented Based on Function, Application, And Geography.

Lactoferrin Market, By Function

• Iron Absorption
• Anti-Inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Based on Function, the market is segmented into Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant. The iron absorption segment generated the most revenue in 2022 and is predicted to continue its lead throughout the projection period. Iron deficiency frequently results in anemia, which affects around 30% of the world's population. Lactoferrin has been a critical remedy for anemia because of its high bioavailability and capacity to enhance serum ferritin levels by five times when compared to other iron sources. According to the WHO, anemia affects about 1.62 billion people worldwide, with pre-school-aged children having the highest incidence, accounting for 47.4% of the total afflicted population.

Lactoferrin Market, By Application

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Based on Application, the market is segmented into Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, and Animal Feed. In 2022, the baby formula category led the Lactoferrin Market, accounting for the biggest revenue share. From 2023 to 2030, the category is predicted to grow at a stable CAGR. The increased number of clinical studies supporting baby formula integration with lactoferrin, as well as changing consumer dynamics towards newborn supplemental meals, are expected to drive demand. The demand for newborn nourishment is primarily from developed economies, owing to high disposable money, hectic work schedules, and increased rates of iron deficiency in newborns.

Lactoferrin Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Lactoferrin Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2022, Asia Pacific will be the largest regional market. Throughout the projection period, the regional market is likely to maintain its position. The regional market expansion, led by India, China, and Japan, may be attributable to increased population and consumer purchasing capacity. Unlike most other areas, Asia Pacific contains a substantial number of middle and small firms.

• Furthermore, increased consumer knowledge about newborn nutrition, personal care, and pharmaceutical goods, as well as consumer preference for organic products, are likely to boost the market for lactoferrin in the area. In 2022, North America was the second-largest geographic market for lactoferrin. The United States has emerged as the region's largest market. The rising prevalence of digestive problems has increased product demand across the country.

Key Players

The "Global Lactoferrin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as InVitria, Hilmar Cheese Company, Glanbia plc, Pharming Group NV, APS BioGroup, FrieslandCamina, Synlait Milk Ltd., Ferrin-tech LLC, Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, Milei GmbH.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2022, Before it can be licensed for sale on the market, leniolisib, a possible therapy for activated phosphoinositide 3-kinase delta syndrome (APDS) in children, must first go through the regulatory procedure of having an agreed-upon Paediatric Investigation Plan (PIP). Leniolisib has been designated as a Promising Innovative Medicine (PIM), indicating that it may be eligible for the MHRA's Early Access to Medicines Scheme.
• In May 2021, Laura Kelly, Governor of Kansas, and Hilmar Cheese Company, Inc. officials announced that the company has opted to build a brand new, cutting-edge cheese and whey protein production plant in Dodge City, Kansas.
• In September 2020, FrieslandCampina WAMCO completed the acquisition of Nuticima's dairy business. This acquisition has improved Friesl and Campina's production capacity, allowing them to meet the rising demand in Nigeria for powder milk and evaporated milk.
• In October 2020, Milei GmbH reported an increase in lactoferrin manufacturing capacity to 170 tonnes, more than doubling the capacity in 2019. The net investment will be USD 18.3 million.
• In September 2020, FrieslandCampina Ingredients said that it would boost its lactoferrin production capacity in Veghel, Netherlands, by 60 metric tonnes by 2022. This will aid the company's strategic growth in the Early Life Nutrition and Adult Nutrition areas. FrieslandCampina Ingredients will be the world's largest manufacturer of lactoferrin, with a new capacity of 70 mt per year.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Lactoferrin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Lactoferrin Market gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LACTOFERRIN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LACTOFERRIN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LACTOFERRIN MARKET, BY FUNCTION

• 5.1 Overview
• 5.2 Iron Absorption
• 5.3 Anti-Inflammatory
• 5.4 Intestinal Flora Protection
• 5.5 Antibacterial
• 5.6 Immune Cell Stimulation
• 5.7 Antioxidant

6 GLOBAL LACTOFERRIN MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Food & Beverages
• 6.3 Infant Formula
• 6.4 Sports & Functional Foods
• 6.5 Pharmaceuticals
• 6.6 Personal Care Products
• 6.7 Animal Feed

7 GLOBAL LACTOFERRIN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL LACTOFERRIN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 InVitria
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hilmar Cheese Company
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Glanbia plc
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Pharming Group NV
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 APS BioGroup
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 FrieslandCamina
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Synlait Milk Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ferrin-tech LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Ingredia SA
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Tatura Milk Industries Ltd.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research